Folks who have seen my post-mastectomy video have been asking for more information about paravertebral blocks.  Here is my rationale for making this choice and my own personal experience with this type of breast surgery anesthesia. Paravertebral blocks have recently been shown to reduce the risk of relapse and death when used with a […]

{ 0 comments }

I’m Back!

by Gwen on March 3, 2014

Well, it has been a real roller coaster ride since I last posted. The iResearch project was put on hold when I was diagnosed with breast cancer last summer.  I took hormone therapy for 7 months and then had a double mastectomy on 1/6/14.  Here’s my goofy yet informative post-mastectomy video diary: I’m happy to […]

{ 0 comments }

It’s been a while since I last posted. My latest project has been taking up my free time – I’m working on an online crowd-sourced research database for those with metastatic breast cancer. Many of us involved in the breast cancer world are too familiar with the shortcomings of clinical research.  It takes too long […]

{ 0 comments }

  Please see my original post on everolimus here Today, the prestigous New England Journal of Medicine published results of the eagerly anticipated BOLERO 2 clinical trial[1]. It showed that adding everolimus (brand name Afinitor) to exemestane (brand name Aromasin, an aromatase inhibitor) greatly improved outcomes for women with metastatic and advanced hormone-positive (ER+ and/or […]

{ 0 comments }

You can find an overview of the most important presentations of the 2011 San Antonio Breast Cancer Symposium here. A couple of weeks ago, a client of mine was diagnosed with ER-positive, HER2-negative breast cancer. At the time of our consultation, I could not find the report that gave any details – only that she […]

{ 0 comments }

Gwen’s best of SABCS 2011: Diligently taking hormone therapy increases survival in metastatic breast cancer

January 24, 2012

You can find an overview of the most important presentations of the 2011 San Antonio Breast Cancer Symposium here. #P1-08-12 by T I Barron and others First comes the diagnosis of breast cancer. Then comes the cancer surgery. This is often followed by grueling chemotherapy or radiation protocols. Just when you’re about to declare victory […]

Read the full article

Gwen’s best of SABCS 2011: Circulating Tumor Cells Can Predict Relapse in Non-metastatic Breast Cancer Patients

January 8, 2012

You can find an overview of the most important presentations of the 2011 San Antonio Breast Cancer Symposium here. Poster #4-07-07 by A. Lucci and others. For a while now, we have seen how a simple blood test that measures circulating tumor cells (CTCs) can predict response to treatments for metastatic breast cancer. Now we […]

Read the full article

Gwen’s best of SABCS 2011: Blood test predicts risk of heart problems after trastuzumab (Herceptin)

January 8, 2012

You can find an overview of the most important presentations of the 2011 San Antonio Breast Cancer Symposium here. Poster #5-20-02 by I. Blancas and others Significant heart problems develop in about 25% of those taking trastuzumab. Early identification is important to minimize the risk of overt heart failure. In this study, measuring a blood […]

Read the full article

Gwen’s best of SABCS 2011: Oncotype DX test underestimates HER2

January 8, 2012

You can find an overview of the most important presentations of the 2011 San Antonio Breast Cancer Symposium here. Poster #01-07-20 by D. J. Dabbs and others The Oncotype DX test is amazing. The folks at Genomic Health who developed it are my personal heroes. But recently a problem has cropped up. Genomic Health may […]

Read the full article

Gwen’s best of SABCS 2011: Isolated tumor cells (ITCs) and micrometases in lymph nodes do NOT worsen overall survival

January 8, 2012

You can find an overview of the most important presentations of the 2011 San Antonio Breast Cancer Symposium here. Poster #3-07-34 by A. Valachis and others There has been a lot of debate as to whether very tiny deposits of cancer cells found in lymph nodes removed at the time of breast surgery mean increased […]

Read the full article